These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 8563622)

  • 1. Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus).
    Itoh S; Navia MA
    Protein Sci; 1995 Nov; 4(11):2261-8. PubMed ID: 8563622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FK506-binding protein mutational analysis: defining the active-site residue contributions to catalysis and the stability of ligand complexes.
    DeCenzo MT; Park ST; Jarrett BP; Aldape RA; Futer O; Murcko MA; Livingston DJ
    Protein Eng; 1996 Feb; 9(2):173-80. PubMed ID: 9005438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex.
    Kissinger CR; Parge HE; Knighton DR; Lewis CT; Pelletier LA; Tempczyk A; Kalish VJ; Tucker KD; Showalter RE; Moomaw EW
    Nature; 1995 Dec; 378(6557):641-4. PubMed ID: 8524402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the interaction between FK506 and FKBP12: a mechanism for formation of the calcineurin inhibitory complex.
    Ivery MT; Weiler L
    Bioorg Med Chem; 1997 Feb; 5(2):217-32. PubMed ID: 9061187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of FK506 bound to the R42K, H87V double mutant of FKBP-12.
    Lepre CA; Pearlman DA; Cheng JW; DeCenzo MT; Livingston DJ; Moore JM
    Biochemistry; 1994 Nov; 33(46):13571-80. PubMed ID: 7524662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex.
    Griffith JP; Kim JL; Kim EE; Sintchak MD; Thomson JA; Fitzgibbon MJ; Fleming MA; Caron PR; Hsiao K; Navia MA
    Cell; 1995 Aug; 82(3):507-22. PubMed ID: 7543369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mean field analysis of FKBP12 complexes with FK506 and rapamycin: implications for a role of crystallographic water molecules in molecular recognition and specificity.
    Rejto PA; Verkhivker GM
    Proteins; 1997 Jul; 28(3):313-24. PubMed ID: 9223178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charged surface residues of FKBP12 participate in formation of the FKBP12-FK506-calcineurin complex.
    Aldape RA; Futer O; DeCenzo MT; Jarrett BP; Murcko MA; Livingston DJ
    J Biol Chem; 1992 Aug; 267(23):16029-32. PubMed ID: 1379588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan dynamics of the FK506 binding protein: time-resolved fluorescence and simulations.
    Silva ND; Prendergast FG
    Biophys J; 1996 Mar; 70(3):1122-37. PubMed ID: 8785272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FK506 binding protein mutational analysis. Defining the surface residue contributions to stability of the calcineurin co-complex.
    Futer O; DeCenzo MT; Aldape RA; Livingston DJ
    J Biol Chem; 1995 Aug; 270(32):18935-40. PubMed ID: 7642551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus preferred hydration sites in six FKBP12-drug complexes.
    Faerman CH; Karplus PA
    Proteins; 1995 Sep; 23(1):1-11. PubMed ID: 8539241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proposed molecular model for the interaction of calcineurin with the cyclosporin A-cyclophilin A complex.
    Ivery MT
    Bioorg Med Chem; 1999 Jul; 7(7):1389-402. PubMed ID: 10465413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional structure and actions of immunosuppressants and their immunophilins.
    Braun W; Kallen J; Mikol V; Walkinshaw MD; Wüthrich K
    FASEB J; 1995 Jan; 9(1):63-72. PubMed ID: 7529736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcineurin-immunosuppressor complexes.
    Stoddard BL; Flick KE
    Curr Opin Struct Biol; 1996 Dec; 6(6):770-5. PubMed ID: 8994877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands.
    Cardenas ME; Hemenway C; Muir RS; Ye R; Fiorentino D; Heitman J
    EMBO J; 1994 Dec; 13(24):5944-57. PubMed ID: 7529175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemistry of signal transduction.
    Clardy J
    Proc Natl Acad Sci U S A; 1995 Jan; 92(1):56-61. PubMed ID: 7529414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Context-dependent nature of destabilizing mutations on the stability of FKBP12.
    Main ER; Fulton KF; Jackson SE
    Biochemistry; 1998 Apr; 37(17):6145-53. PubMed ID: 9558354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of a rapamycin-based high affinity binding FKBP12 ligand.
    Chakraborty TK; Weber HP; Nicolaou KC
    Chem Biol; 1995 Mar; 2(3):157-61. PubMed ID: 9383417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface.
    Luengo JI; Yamashita DS; Dunnington D; Beck AK; Rozamus LW; Yen HK; Bossard MJ; Levy MA; Hand A; Newman-Tarr T
    Chem Biol; 1995 Jul; 2(7):471-81. PubMed ID: 9383449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic NMR studies of ligand-receptor interactions: design and analysis of a rapidly exchanging complex of FKBP-12/FK506 with a 24 kDa calcineurin fragment.
    Fejzo J; Lepre CA; Peng JW; Su MS; Thomson JA; Moore JM
    Protein Sci; 1996 Sep; 5(9):1917-21. PubMed ID: 8880916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.